 Amicus Therapeutics Inc NASDAQ: FOLD has agreed to spin off its gene therapy business to Sciences Acquisition Corp IV NASDAQ: ARYD and launch genetic medicine company Caritas Therapeutics Inc. ARYA Sciences Acquisition Corp IV is SPAC, sponsored by Perceptive Advisors. 